Ionic Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ionic Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-50,000	Closed	-$3.59M	–	156
2018 Q4	$3.59M	Sell	50,000 -10,000	-17%	-$806K	0.36%	30
2018 Q3	$5.75M	Buy	60,000 +10,000	+20%	+$970K	0.49%	31
2018 Q2	$4.76M	Buy	+50,000	New	+$4.6M	0.28%	55
2018 Q1	–	Sell	-182,000	Closed	-$15.4M	–	338
2017 Q4	$15.4M	Hold	182,000	–	–	0.64%	27
2017 Q3	$15.8M	Hold	182,000	–	–	0.63%	25
2017 Q2	$14M	Hold	182,000	–	–	0.75%	29
2017 Q1	$12.6M	Hold	182,000	–	–	0.78%	30
2016 Q4	$10.8M	Buy	182,000 +132,000	+264%	+$8.15M	0.58%	49
2016 Q3	$3.31M	Buy	+50,000	New	+$3.09M	0.15%	141

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Ionic Capital Management's XBI Position: Q4 2024 in Review

Ionic Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 9,650 shares — an estimated $953K sold.

Ionic Capital Management first reported a position in XBI in Q4 2016 and held it in 16 quarters. The position peaked at $2.31M in Q2 2017. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

Ionic Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
Ionic Capital Management sold 9,650 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $953K.
Ionic Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 16 quarters.
Ionic Capital Management's State Street SPDR S&P Biotech ETF position peaked at $2.31M in Q2 2017.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Ionic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.